Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rewiring mitochondrial metabolism to counteract exhaustion of CAR-T cells
Yue Huang, Xiaohui Si, Mi Shao, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Editorial: Targeting metabolism to activate T cells and enhance the efficacy of checkpoint blockade immunotherapy in solid tumors
Zhijia Xia, Shi Chen, Miao He, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 42
Mitochondrial isocitrate dehydrogenase impedes CAR T cell function by restraining antioxidant metabolism and histone acetylation
Xiaohui Si, Mi Shao, Xinyi Teng, et al.
Cell Metabolism (2024) Vol. 36, Iss. 1, pp. 176-192.e10
Closed Access | Times Cited: 32
Inhibition of CD38 enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism
Yue Huang, Mi Shao, Xinyi Teng, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101400-101400
Open Access | Times Cited: 19
Prospects and challenges of CAR-T cell therapy combined with ICIs
Yufan Lv, Xinyu Luo, Zhuoyi Xie, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 17
Novel strategies to manage CAR-T cell toxicity
Arthur Mulvey, Lionel Trueb, George Coukos, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 4
Strategies to enhance CAR-T persistence
Yue Liu, Lingna An, Ruihao Huang, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 52
Mitochondrial transfer in tunneling nanotubes—a new target for cancer therapy
Fan Guan, Xiaomin Wu, Jiatong Zhou, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 15
Deciphering the tumor immune microenvironment from a multidimensional omics perspective: insight into next-generation CAR-T cell immunotherapy and beyond
Zhaokai Zhou, Jiahui Wang, Jiaojiao Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Biomarkers for prediction of CAR T therapy outcomes: current and future perspectives
Lucija Levstek, Larisa Janžič, Alojz Ihan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Complete sequence and comparative analysis of the mitochondrial genome of the rare and endangered Clematis acerifolia, the first clematis mitogenome to provide new insights into the phylogenetic evolutionary status of the genus
Dan Liu, Kai Qu, Yangchen Yuan, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 20
Targeting of chimeric antigen receptor T cell metabolism to improve therapeutic outcomes
Priyanka Maridhi Nanjireddy, Scott H. Olejniczak, Nataliya P. Buxbaum
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Advances in CAR‐Engineered Immune Cell Generation: Engineering Approaches and Sourcing Strategies
Zhaozhao Chen, Yu Hu, Heng Mei
Advanced Science (2023) Vol. 10, Iss. 35
Open Access | Times Cited: 16
T cell exhaustion in human cancers
Kuan Kang, Xin Lin, Pan Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189162-189162
Closed Access | Times Cited: 7
Unlocking the potential of T‐cell metabolism reprogramming: Advancing single‐cell approaches for precision immunotherapy in tumour immunity
Lihaoyun Huang, Haitao Li, Cangang Zhang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 6
CRISPR-Cas gene knockouts to optimize engineered T cells for cancer immunotherapy
Valentine De Castro, Jeanne Galaine, Romain Loyon, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 8, pp. 1124-1134
Closed Access | Times Cited: 5
Chimeric antigen receptor T cells in the treatment of osteosarcoma (Review)
Tong Yu, Weibo Jiang, Yang Wang, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 4
Open Access | Times Cited: 4
Fueling CARs: metabolic strategies to enhance CAR T-cell therapy
Arne Van der Vreken, Karin Vanderkerken, Elke De Bruyne, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy
Chen Chen, Peng Han, Yanping Qing
Autoimmunity Reviews (2024) Vol. 23, Iss. 6, pp. 103579-103579
Closed Access | Times Cited: 4
Improved Efficacy of Triple‐Negative Breast Cancer Immunotherapy via Hydrogel‐Based Co‐Delivery of CAR‐T Cells and Mitophagy Agonist
Guodong Li, Ruoxin Du, Donghui Wang, et al.
Advanced Science (2025)
Open Access
Charged substrate treatment enhances T cell mediated cancer immunotherapy
Jia Song, Yanhui Lu, Lulu Liu, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
One-carbon metabolism is distinct metabolic signature for proliferative intermediate exhausted T cells of ICB-resistant cancer patients
Ye-Chan Park, Yeseong Hwang, Jae Woong Jeong, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Novel NIR-Ⅱ-Activated titanate-supported iridium nanoplatform delivers multimodal antitumor therapy synergistic with PD-1 inhibition in TNBC
Peixin Du, Xian Jiang, Zihan Xu, et al.
Chemical Engineering Journal (2025), pp. 160659-160659
Closed Access
The potential role of the thymus in immunotherapies for acute myeloid leukemia
Christopher Hino, Yi Xu, Jeffrey Xiao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Allogeneic chimeric antigen receptor-T cells with CRISPR-disrupted programmed death-1 checkpoint exhibit enhanced functional fitness
Elaine K. Lau, George Kwong, Tristan W. Fowler, et al.
Cytotherapy (2023) Vol. 25, Iss. 7, pp. 750-762
Open Access | Times Cited: 10
Bruton tyrosine kinase inhibitors preserve anti-CD19 chimeric antigen receptor T-cell functionality and reprogram tumor micro-environment in B-cell lymphoma
Wenjing Luo, Chenggong Li, Jianghua Wu, et al.
Cytotherapy (2023) Vol. 25, Iss. 7, pp. 739-749
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top